Talk:Disitamab vedotin

Feedback from New Page Review process
I left the following feedback for the creator/future reviewers while reviewing this article: Thanks for creating this page for a therapeutic compound in clinical use. It's appropriately marked as a stub, but can grow from here.

Klbrain (talk) 19:22, 19 July 2024 (UTC)